UPDATE: Morgan Stanley Reiterates on Genpact Limited Following Mixed Quarter Results

In a report published Friday, Morgan Stanley analyst Vipin Khare reiterated an Overweight rating on Genpact Limited (NYSE: G ), but removed the $21.00 price target. In the report, Morgan Stanley noted, “Genpact reported a mixed set of Dec13 quarter results. Revenues and adj net income were ahead of our